No menu items!

Tag: Registration was granted to the laboratory GlaxoSmithKline Brasil Ltda

RIO DE JANEIRO, BRAZIL - The Brazilian Health Regulatory Agency (ANVISA) has approved the first HIV treatment combining two different substances in a single pill. The new drug is a combination of lamivudine and sodium dolutegravir. Previously, patients were required...

LATEST NEWS

WEATHER

Rio de Janeiro
few clouds
26.7 ° C
31 °
26 °
75 %
4.6kmh
20 %
Thu
30 °
Fri
30 °
Sat
29 °
Sun
29 °
Mon
31 °